Market Closed - London S.E. 11:35:07 2024-04-19 am EDT 5-day change 1st Jan Change
445 GBX -4.30% Intraday chart for Tristel plc -7.29% -3.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tristel CEO Paul Swinney sells GBP230,000 in shares AN
Tristel doubles dividend on revenue and profit boost in first half AN
Tristel's Sporicidal Disinfectant System Receives Positive Recommendation from Regulators in UK, EU MT
Tristel plc Recommends Interim Dividend, Payable on 12 April 2024 CI
Tristel plc Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Tristel gets approval in Canada for ULT ultrasound disinfectant device AN
Tristel Receives Canadian Approval for Disinfectant Device MT
Tristel plc Announces Canadian Regulatory Approval for Tristel Ult as a high-level disinfectant CI
Tristel optimistic of strong second half following good start to year AN
Paul Swinney Intends to Retire as Group CEO of Tristel plc CI
Tristel plc Provides Revenue Guidance for the Six Months Ending December 31, 2023 CI
FTSE 100 Closes Up Supported by Basic Resources, Energy Stocks DJ
Tristel's annual profit multiplies; outlook "strongest" in 30 years AN
Earnings Flash (TSTL.L) TRISTEL Posts FY23 Revenue GBP36M MT
Tristel plc Recommends Final Dividend, Payable on 22 December 2023 CI
Tristel plc Reports Earnings Results for the Full Year Ended June 30, 2023 CI
FTSE 100 to rise as oil consolidates gains AN
Stocks red as rate fears weigh on investors AN
Stocks lower as conflict and rate fears weigh AN
Tristel submits to Health Canada for Tristel ULT medical approval AN
Tristel plc Announces Regulatory Approval for EPA, Canada and South Korea CI
Liberum Starts Coverage of Tristel with Hold Rating MT
Liberum starts Tristel with 'hold' AN
Tristel CEO Paul Swinney sells GBP350,000 in shares AN
FTSE 100 Closes Tuesday Up 0.2% Lifted by Unilever, Miners DJ
Chart Tristel plc
More charts
Tristel plc is a United Kingdom-based manufacturer of infection prevention products. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company’s segments include Hospital medical device decontamination, Hospital environmental surface disinfection and others. The Company manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. The Company is also focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, surfaces, ultrasound, urology, hand hygiene and women's health.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.65 GBP
Average target price
4.817 GBP
Spread / Average Target
+3.58%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TSTL Stock
  4. News Tristel plc
  5. US FDA Asks Tristel for Additional Data in Application for Ultrasound Disinfectant; Stock Down 5%